Open original FDA record ↗Recall record
- FDA identifier
- Z-0606-06
- Company in FDA record
- Biogenex Laboratories
- FDA classification date
- Mar 15, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Products produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
Source facts
- Action
- On 2/9/06, the firm issued letters via UPS to all of its consignees, informing them of the affected products and providing instructions on the recall.
- Initiated
- 2006-02-09
- Root cause
- Other
- Terminated
- 2006-08-23
- Distribution
- Nationwide. Italy, and United Kingdom. The product was released for distribution to 21 consignees nationwide to CA, FL, GA, IA, IL, NC, NJ, NY, TX, VT, WA, and WI. One VA account: VA Medical Center, Gwen Levy, Bld. 500, Room 1238, 11301 Wilshire Blvd., Los Angeles, CA 90073. 2 overseas consignees distributed the product to Italy (Space Imports Export SPL, Via Ranzato, 12, 1-20128 Milano, Italy and United Kingdom (Launch Diagnosis, West Yoke Farm unit 11, Michaels, Lane, Sevenoaks, Kent, TN15 7EP United Kingdom
- Recall number
- Z-0606-06
- Recall status
- Terminated
- CDRH record ID
- 44141
- FDA classified
- 2006-03-15
- Recall event number
- 34586